These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12789271)

  • 1. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.
    Oshiro MM; Watts GS; Wozniak RJ; Junk DJ; Munoz-Rodriguez JL; Domann FE; Futscher BW
    Oncogene; 2003 Jun; 22(23):3624-34. PubMed ID: 12789271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
    Primeau M; Gagnon J; Momparler RL
    Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of maspin gene expression in human breast cancers.
    Domann FE; Rice JC; Hendrix MJ; Futscher BW
    Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
    Wozniak RJ; Klimecki WT; Lau SS; Feinstein Y; Futscher BW
    Oncogene; 2007 Jan; 26(1):77-90. PubMed ID: 16799634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
    Alvarez Secord A; Darcy KM; Hutson A; Huang Z; Lee PS; Jewell EL; Havrilesky LJ; Markman M; Muggia F; Murphy SK
    Gynecol Oncol; 2011 Nov; 123(2):314-9. PubMed ID: 21903246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter.
    Rice JC; Futscher BW
    Nucleic Acids Res; 2000 Sep; 28(17):3233-9. PubMed ID: 10954590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer.
    Maass N; Biallek M; Rösel F; Schem C; Ohike N; Zhang M; Jonat W; Nagasaki K
    Biochem Biophys Res Commun; 2002 Sep; 297(1):125-8. PubMed ID: 12220518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
    Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
    Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
    Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
    Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
    Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
    Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of DSC3 is a common event in human breast cancer.
    Oshiro MM; Kim CJ; Wozniak RJ; Junk DJ; Muñoz-Rodríguez JL; Burr JA; Fitzgerald M; Pawar SC; Cress AE; Domann FE; Futscher BW
    Breast Cancer Res; 2005; 7(5):R669-80. PubMed ID: 16168112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of the maspin promoter is an early event in human breast cancer.
    Futscher BW; O'Meara MM; Kim CJ; Rennels MA; Lu D; Gruman LM; Seftor RE; Hendrix MJ; Domann FE
    Neoplasia; 2004; 6(4):380-9. PubMed ID: 15256060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control.
    Fitzgerald M; Oshiro M; Holtan N; Krager K; Cullen JJ; Futscher BW; Domann FE
    Neoplasia; 2003; 5(5):427-36. PubMed ID: 14670180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR; Moore BC; Ririe TO; Jones DA
    Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.